ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Ivz Sp Eqw A

Ivz Sp Eqw A (SPEX)

4 697,25
10,75
(0,23%)
Fermé 29 Décembre 5:30PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
4 697,25
Prix Achat
4 693,50
Prix Vente
4 704,50
Volume échangé
3 142
4 692,50 Fourchette du Jour 4 774,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
4 686,50
Ouverture
4 774,00
Dernière Transaction
3
@
4698
(AT)
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
149 482p
VWAP
4 757,5366

SPEX Dernières nouvelles

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 30 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P 500 Equal Weight UCITS ETF Acc 29/04/2021...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 28 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P 500 Equal Weight UCITS ETF Acc 19/04/2021...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 28 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P 500 Equal Weight UCITS ETF Acc 27/04/2021...

IVZ II SP500 Eq We UCITS ETF AC GBP Net Asset Value(s)

IVZ II SP500 Eq We UCITS ETF AC GBP 19 April 2021 NAV/per Shares in Net Asset share Funds Date ISIN code Issue Currency Value Base Invesco S&P 500 Equal Weight UCITS ETF Acc 18/04/2021...

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq SPEX), an innovator in biotechnology for diabetes...

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces Results of Annual Shareholders Meeting

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock